Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children.

Angsuwatcharakon P, Khomvilai S, Limsuwun K, Ratananpinit N, Khamchat A, Sanitnai T, Tantawichien T.

Expert Rev Vaccines. 2018 Feb;17(2):185-188. doi: 10.1080/14760584.2018.1421074. Epub 2018 Jan 10.

PMID:
29285961
2.

New method to produce equine antirabies immunoglobulin F(ab')₂ fragments from crude plasma in high quality and yield.

Kittipongwarakarn S, Hawe A, Tantipolphan R, Limsuwun K, Khomvilai S, Puttipipatkhachorn S, Jiskoot W.

Eur J Pharm Biopharm. 2011 Jun;78(2):189-95. doi: 10.1016/j.ejpb.2011.02.018. Epub 2011 Mar 21.

PMID:
21414404
3.
4.

An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan.

Benjavongkulchai M, Kositprapa C, Limsuwun K, Khawplod P, Thipkong P, Chomchey P, Yountong C, Naraporn N, Ayuthya AB, Raksakate S, Samranwetaya P, Oka T, Ohkuma K, Hamasaki T, Wilde H.

Vaccine. 1997 Dec;15(17-18):1816-9.

PMID:
9413087
5.

Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.

Kositprapa C, Limsuwun K, Wilde H, Jaijaroensup W, Saikasem A, Khawplod P, Kri-aksorn U, Supich C.

Clin Infect Dis. 1997 Sep;25(3):614-6.

PMID:
9314448

Supplemental Content

Loading ...
Support Center